February
Ramsay says Labor’s premium hike will not cover soaring hospital costs
Still, shares in the country’s largest private hospital operator rose sharply after it appointed Goldman Sachs to assess the sale of its European business.
Health insurance premiums to rise 3.7pc in new cost-of-living hit
Health Minister Mark Butler has signed off on an above-inflation hike in private health insurance premiums, the biggest rise since 2018.
Big pharma sues GenesisCare over Labor-endorsed copycat cancer drug
Swiss pharma giant Novartis is taking legal action against the Australian cancer care provider as a dispute over how to fund and regulate nuclear medicines escalates.
Dutton to match Labor’s GP funding in big-spending campaign pledge
The opposition leader promises to match Labor’s $8.5 billion GP funding pledge as he seeks to defend his record on health.
Why a Mediscare campaign won’t be so easy this time around
Labor’s Medicare package offers politically popular relief for GP visits but may not convince voters losing confidence in Australia’s public health system.
Doctors say not all GP visits will be free under Labor plan
Medical professionals welcome the $8.5 billion Medicare overhaul but urge targeted funding to care for patients who need it most.
Star biotech Telix makes $1.2b revenue pledge
The Melbourne-based nuclear medicine company is expected to be a major player in the US radiopharmaceutical market.
US pharma giant Cosette makes $672m bid for Mayne Pharma
US pharma giant Cosette has offered $7.40 a share for Mayne Pharmaceuticals, a premium to recent trading but a fraction of the $42 it was trading at in 2016.
Healthscope to close maternity wards in Darwin and Hobart
The Coalition has seized on the shutdowns to accuse Labor of failing to take action to stop the closure of critical health service
TGA approves weight-loss drug to treat heart disease
Regulators say the weight-loss drug Wegovy can now be used to treat more than 3 million overweight Australians with heart disease.
Catholic Health’s new plan to fix hospitals at ‘breaking point’
Private hospital groups have sent Labor a package of proposals they say can save the struggling sector.
David Di Pilla’s HMC Capital eyes Healthscope hospitals
The alternative asset manager and other operators are talking to Healthscope’s landlords about taking over Australia’s second-biggest hospital group.
Cochlear says US cost-of-living pressures hit services revenue
Cochlear expects full-year earnings to come in at the lower end of guidance, despite rising sales of its implants.
Healthscope loses chief executive and chairman amid debt pain
The country’s second-largest private hospital operator has appointed former Qantas executive Tino La Spina to take over as it negotiates with lenders.
Chemist Warehouse scores $34b pay day in ASX debut
The founders were on hand as the retailer made its sharemarket debut on Thursday via Sigma, with plans to expand in Australia and globally.
Gap in insurer refunds ‘shows need for health fund reform’
Doctors want an independent private health system authority to oversee conflicts between insurers and hospital groups over funding.
Ramsay warns of no profit growth as it slashes British assets
Ramsay Health Care’s new chief executive, Natalie Davis, says first-half earnings will be weaker this year because of offshore impairments.
CSL war games manufacturing network in a world heading for trade war
The ASX-listed giant says it can switch manufacturing sites if Donald Trump imposes tariffs on pharmaceuticals. It expects double-digit earnings growth.
Doctors pitch $3b plan to slash GP visit costs
GPs will on Tuesday present a funding package to Canberra they say will make doctor visits affordable for younger Australians and people with chronic illness.
Mayne Pharma expects earnings to triple, shares jump 24pc
Shares in volatile drugmaker Mayne Pharma jumped 24 per cent on Monday after the company said it expected stronger first-half earnings and revenues.